Besides, FAK inhibition with TAE-226 re-sensitized resistant ovarian cancer cells to doxorubicin and promoted tumor regression by inhibiting angiogenesis, invasion, and inducing apoptosis levels [94]. Here, PTK2 is linked to ovarian cancer.